Nevertheless, because of their distribution in metastatic sites (lung or liver), LNC–WS12s could be used to target metastasis dissemination in patients with prostate cancer before anti–androgenic therapy and the subsequent loss of TRPM8 expression [23]. The gene discussed is TRPM8; the disease is prostate carcinoma.